Correlation Between Tarsus Pharmaceuticals and ACGCAP

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and ACGCAP at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and ACGCAP into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and ACGCAP 195 30 JAN 26, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and ACGCAP and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of ACGCAP. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and ACGCAP.

Diversification Opportunities for Tarsus Pharmaceuticals and ACGCAP

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between Tarsus and ACGCAP is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and ACGCAP 195 30 JAN 26 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ACGCAP 195 30 and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with ACGCAP. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ACGCAP 195 30 has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and ACGCAP go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and ACGCAP

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.35 times more return on investment than ACGCAP. However, Tarsus Pharmaceuticals is 2.85 times less risky than ACGCAP. It trades about 0.23 of its potential returns per unit of risk. ACGCAP 195 30 JAN 26 is currently generating about -0.09 per unit of risk. If you would invest  5,179  in Tarsus Pharmaceuticals on October 7, 2024 and sell it today you would earn a total of  388.00  from holding Tarsus Pharmaceuticals or generate 7.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy70.0%
ValuesDaily Returns

Tarsus Pharmaceuticals  vs.  ACGCAP 195 30 JAN 26

 Performance 
       Timeline  
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

26 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 26 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
ACGCAP 195 30 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ACGCAP 195 30 JAN 26 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for ACGCAP 195 30 JAN 26 investors.

Tarsus Pharmaceuticals and ACGCAP Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tarsus Pharmaceuticals and ACGCAP

The main advantage of trading using opposite Tarsus Pharmaceuticals and ACGCAP positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, ACGCAP can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACGCAP will offset losses from the drop in ACGCAP's long position.
The idea behind Tarsus Pharmaceuticals and ACGCAP 195 30 JAN 26 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon